INHIBITION OF GASTRIC ACID SECRETION BY INTRAVENOUS PANTOPRAZOLE

静脉注射泮托拉唑抑制胃酸分泌

• 批准号: 6263609
• 负责人: DAVID C METZ
• 金额: $ 2.51万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6263609
• 关键词: Zollinger Ellison syndrome; benzimidazoles; clinical research; drug screening /evaluation; gastric acid; gastrointestinal disorder chemotherapy; human subject; human therapy evaluation; intravenous administration; membrane transport proteins; secretion; sulfoxide

This trial will monitor the safety of intravenous pantopraxole and to establish its regimen as an alternative to oral proton pump inhibitors for control of gastric acid secretion in patients with Zollinger-Ellison Syndrome (ZES).

这项试验将监测静脉注射潘托拉索的安全性，并建立其方案作为口服质子泵抑制剂的替代方案，以控制Zollinger-Ellison综合征(ZES)患者的胃酸分泌。